Cocrystal Pharma Inc. (COCP)

Influenza Program Update


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
September 12, 2022
Report ID: 25202
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Cocrystal Pharma Inc.
Cocrystal Pharma Inc.
Healthcare
Biotechnology
Ticker
COCP
Current Price
$3.05 5.54%
Market Cap
$24.8M
Price Target
Refer to Report
Volume
53.5K
52wk Range
$1.74 - $7.5588

Comments

0
No comments yet...
Related Research Reports
12/20/2022

Safety and Tolerability Data From Influenza Study Announced
Safety and Tolerability Data From Influenza Study Announced (COCP)
11/16/2022

3Q22 Reported – First Influenza Vaccine Data To Be Presented
3Q22 Reported – First Influenza Vaccine Data To Be Presented (COCP)
9/12/2022

Influenza Program Update
Influenza Program Update (COCP)
8/16/2022

2Q Reported With Influenza and COVID-19 Product Updates
2Q Reported With Influenza and COVID-19 Product Updates (COCP)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2023 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.